German pharmaceutical company Bayer and Yunona Holdings, representing the Ural Pharmaceutical Cluster (UPC) of Russia have entered a memorandum of understanding to manufacture drugs in Russia. The companies intend to establish themselves in the fields of production, marketing and distribution of pharmaceutical products in Russia, inpharm.com reported.The UPC which is a complex of interconnected production and infrastructure facilities is known to manufacture and sell medicines and medical equipment.The cluster has received funds worth 27.3 bn roubles (around $860m) from Russia’s economic development programme between 2010 and 2015.
Bayer joins Russian firm to manufacture drugs
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Media Packs
Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!
– Access the Media Pack Now
– Book a Conference Call
– Leave Message for Us to Get Back
Related stories
Press Releases
New Syngene biologics manufacturing facility to be operational for US and European customers from mid-year
At DCAT 2024 global bio/pharmaceutical manufacturing forum, Syngene International,...
News
ST Pharm breaks ground on 2nd oligonucleotide manufacturing plant
ST Pharm said it has taken its first step...
BioPharma
Elevating Biopharmaceutical Projects With The Right CDMO
In the biopharma industry, selecting the right contract development...
News
Biovian announces over €50 million investment in manufacturing facility in Turku, Finland
Biovian, a leading contract development and manufacturing organization (CDMO)...
Latest stories
